Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Amortization of Deferred Charges (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Amortization of Deferred Charges for 12 consecutive years, with $351000.0 as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 8.67% to $351000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 78.57% year-over-year, with the annual reading at $1.4 million for FY2025, 111.21% up from the prior year.
  • Amortization of Deferred Charges hit $351000.0 in Q4 2025 for Ani Pharmaceuticals, down from $838000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.2 million in Q4 2022 to a low of -$804000.0 in Q4 2021.
  • Historically, Amortization of Deferred Charges has averaged $581684.2 across 5 years, with a median of $590000.0 in 2022.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 236.73% in 2021 and later surged 372.14% in 2022.
  • Year by year, Amortization of Deferred Charges stood at -$804000.0 in 2021, then soared by 372.14% to $2.2 million in 2022, then tumbled by 56.49% to $952000.0 in 2023, then plummeted by 66.07% to $323000.0 in 2024, then increased by 8.67% to $351000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for ANIP at $351000.0 in Q4 2025, $838000.0 in Q3 2025, and $828000.0 in Q2 2025.